Doxazosin
- Product NDC
- 71610-927
- 11-digit product format
- 716100927
- Labeler code
- 71610
- Product ID
- 71610-927_3ab22051-bf7b-5122-e063-6294a90a4f64
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- NDA019668
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2023-01-18
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197627 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-927-53 | Doxazosin | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
| 71610-927-60 | Doxazosin | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
| 71610-927-80 | Doxazosin | 180 in 1 BOTTLE | TABLET | 180 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-927-53 | 71610092753 | 60 TABLET in 1 BOTTLE (71610-927-53) | 60 tablet | 2025-07-18 | No | No | Historical |
| 71610-927-60 | 71610092760 | 90 TABLET in 1 BOTTLE (71610-927-60) | 90 tablet | 2025-07-18 | No | No | Historical |
| 71610-927-80 | 71610092780 | 180 TABLET in 1 BOTTLE (71610-927-80) | 180 tablet | 2025-07-18 | No | No | Historical |